Journavx (suzetrigine) by Vertex Pharmaceuticals represents a major advancement in pain management, offering a non-opioi...
Pharmacology: Armando Genazzani and Monica DiLuca to Lead the Italian Society of Pharmacology (SIF)
The Italian Society of Pharmacology (SIF) announced, during its 42nd National Congress, the appointments of Armando Gena...
Next-generation psychedelics: should new agents skip the trip?
Background Depression affects around 280 million worldwide and one of the major unmet needs is the limited efficacy of t...
New Horizons in Type 1 Diabetes: FDA Approval of Lantidra and Emerging Therapies
The FDA has approved Lantidra, a groundbreaking donor-derived pancreatic islet cell therapy for type 1 diabetes, providi...
Why gene therapies must go virus-free
Gene therapies have made spectacular progress in delivering new cures for previously intractable disease, where virus ve...
Advancement in Metabolic dysfunction-Associated SteatoHepatitis (MASH) treatment: the first FDA approved drug
The FDA approves Madrigal Pharmaceuticals’ Rezdiffra for Metabolic dysfunction-Associated SteatoHepatitis (MASH), ...